Latest News

Glaucoma in Myopia: Diagnostic Dilemmas

Huy Tran, MD Pediatric Ophthalmologist, Myopia Control Clinic, Hai Yen Eye Care PhD candidate, BHVI Myopia is positively associated with glaucoma. However, diagnosing glaucoma in those eyes is a challenge due to the changes in retinal structure and function that result from axial elongation. This article describes potential diagnostic dilemmas that confound diagnosis and monitoring of

Read More »

UPC Optometrist of the Year – Prof. Padmaja Sankaridurg

Head of Myopia Program and Intellectual Property at BHVI, Professor Padmaja Sankaridurg, has been announced as the winner of the 2020 International Optometrist Award by the Facultat d’Optica i Optometria Terrassa (The Terrassa School of Optics and Optometry), Polytechnic University of Catalonia. Professor Sankaridurg will also be the sponsor of this year’s student entry, where she

Read More »

Our Purpose

We fulfil unmet needs in the ophthalmic space by innovating commercially relevant technologies through to feasibility.

We generate ideas.  We push the scientific envelope.  We solve problems.  We translate and communicate our knowledge. We look forward.

Our Values


We focus exclusively on research, development and ophthalmic sector support.


We lead with industry, solving problems and creating technology. We bring new ideas to markets.


We focus on meeting unmet needs. We trial, test, learn, share and adapt. 


We cannot achieve without each other; our team, our partners and our customers.

Learn myopia management with BHVI.

So the next generation can keep

A myopia patient is a lifelong patient.

BHVI’s world leading Myopia Education Program brings you the latest research, clinical procedures, and business expertise.

Copyright © Brien Holden Vision Institute (ABN 49 081 303 282) Brien Holden Vision Institute Foundation (ABN 86 081 872 586). All Rights Reserved.

Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens

SYDNEY, Australia and LAVAL, Quebec, Oct. 15, 2020 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Bausch + Lomb, its leading global eye health business, along with BHVI, an Australian not-for-profit organization with an international focus on vision research, announced today that an affiliate of Bausch Health has acquired an exclusive license for a myopia control contact lens design developed by BHVI. Bausch + Lomb will pair BHVI’s novel contact lens design with its leading contact lens technologies to develop potential contact lens treatments designed to slow the progression of myopia in children.

Our site uses cookies. By continuing to use this website, you agree to their use. For more details, please check our Privacy Policy.